You are here Home Resources and guidance Sponsors Cipla Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type (-) Prescription medicine evaluation (1) ARTG (457) Cancellation by sponsor (239) Cancellation or suspension (79) Prescription medicine registration (45) Cancellation for failure to pay annual charge (17) Australian public assessment report (AusPar) (5) Prescription medicine decision summary (4) Date 2025 (1) Search Filters applied:Prescription medicine evaluationClear all Sponsor content1 result(s) found, displaying 1 to 1 CIPLA TEDUGLUTIDE, REVACIP Cipla Australia Pty Ltd Mar-2025 Prescription medicine evaluation Active ingredient: teduglutide.
CIPLA TEDUGLUTIDE, REVACIP Cipla Australia Pty Ltd Mar-2025 Prescription medicine evaluation Active ingredient: teduglutide.